Delivery Order SPE2DB24D2018-SPE2DB25FWVZ4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,533.99 to AmerisourceBergen Drug Corp for Qualtipta 60 mg tablets (30-count) on July 28, 2025, with performance through July 29, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,337.55 to AmerisourceBergen Drug Corp for the supply of Qualiptа 30 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,373.74 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) with a contract ceiling value of $5,993.70. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The ultimate completion date is set for July 23, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRUQAP 160 mg tablets (16-count units) valued at $15,959.30, with a firm fixed price structure and an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract. The order, valued at $2,400.59, represents a competitive award with no set-aside designation and a completion deadline of July 28, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qualiptа 60 mg tablets (30-count) with a firm fixed price structure. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,157.61 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qualiptia 60 mg tablets in a quantity of 30 units. This contract, which is a non-set-aside award issued under firm fixed pricing, is scheduled for completion by July 31, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award to AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Truqap 200 mg tablets (64-count units) under a firm fixed-price contract with a ceiling value of $15,514.40. This is a competitive award with no set-aside designation, with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVZ4Delivery Order
The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs, including brand-name and generic medications, vaccines, and specialized medical commodities. The DLA has structured its pharmaceutical support through multiple prime vendors to ensure comprehensive coverage across regions, positioning AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/1/25 |